Derma Sciences Cmn (DSCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Sales | 21,810 | 22,208 | 20,243 | 24,632 | 17,788 |
| Cost of Goods | 11,103 | 13,948 | 12,535 | 15,100 | 10,492 |
| Gross Profit | 10,707 | 8,260 | 7,708 | 9,532 | 7,296 |
| Operating Expenses | 16,609 | 11,233 | 10,488 | 14,903 | 12,841 |
| Operating Income | -5,799 | -2,025 | -2,246 | -5,271 | -5,054 |
| Other Income | -231 | 4,535 | 268 | -490 | -672 |
| Pre-tax Income | -6,030 | 2,510 | -1,978 | -5,761 | -5,726 |
| Income Tax | -1,456 | 528 | -220 | -1,546 | -1,052 |
| Net Income Continuous | -4,573 | 1,983 | -1,758 | -4,216 | -4,674 |
| Net Income Discontinuous | 3,182 | N/A | N/A | -5,034 | -4,289 |
| Net Income | $-1,392 | $1,983 | $-1,758 | $-9,249 | $-8,963 |
| EPS Basic Total Ops | -0.05 | 0.08 | -0.07 | -0.36 | -0.35 |
| EPS Basic Continuous Ops | -0.17 | 0.08 | -0.07 | -0.17 | -0.18 |
| EPS Basic Discontinuous Ops | 0.12 | N/A | N/A | -0.19 | -0.17 |
| EPS Diluted Total Ops | -0.05 | 0.08 | -0.07 | -0.36 | -0.35 |
| EPS Diluted Continuous Ops | -0.17 | 0.08 | -0.07 | -0.17 | -0.18 |
| EPS Diluted Discontinuous Ops | 0.12 | N/A | N/A | -0.19 | -0.17 |
| EPS Diluted Before Non-Recurring Items | -0.05 | 0.08 | -0.07 | -0.12 | -0.35 |
| EBITDA(a) | $-4,267 | $-1,039 | $-1,256 | $-4,367 | $-4,067 |